chr3-63912684-G-GGCAGCA
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP3BP6_ModerateBA1
The NM_001377405.1(ATXN7):c.113_118dupAGCAGC(p.Gln38_Gln39dup) variant causes a disruptive inframe insertion change. The variant allele was found at a frequency of 0.106 in 1,086,078 control chromosomes in the GnomAD database, including 4,589 homozygotes. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.098 ( 776 hom., cov: 23)
Exomes 𝑓: 0.11 ( 3813 hom. )
Consequence
ATXN7
NM_001377405.1 disruptive_inframe_insertion
NM_001377405.1 disruptive_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.10
Genes affected
ATXN7 (HGNC:10560): (ataxin 7) The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ADCAI is genetically heterogeneous, with five genetic loci, designated spinocerebellar ataxia (SCA) 1, 2, 3, 4 and 6, being assigned to five different chromosomes. ADCAII, which always presents with retinal degeneration (SCA7), and ADCAIII often referred to as the 'pure' cerebellar syndrome (SCA5), are most likely homogeneous disorders. Several SCA genes have been cloned and shown to contain CAG repeats in their coding regions. ADCA is caused by the expansion of the CAG repeats, producing an elongated polyglutamine tract in the corresponding protein. The expanded repeats are variable in size and unstable, usually increasing in size when transmitted to successive generations. This locus has been mapped to chromosome 3, and it has been determined that the diseased allele associated with spinocerebellar ataxia-7 contains 37-306 CAG repeats (near the N-terminus), compared to 4-35 in the normal allele. The encoded protein is a component of the SPT3/TAF9/GCN5 acetyltransferase (STAGA) and TBP-free TAF-containing (TFTC) chromatin remodeling complexes, and it thus plays a role in transcriptional regulation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP3
Nonframeshift variant in repetitive region in NM_001377405.1
BP6
Variant 3-63912684-G-GGCAGCA is Benign according to our data. Variant chr3-63912684-G-GGCAGCA is described in ClinVar as [Likely_benign]. Clinvar id is 402403.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.132 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATXN7 | NM_001377405.1 | c.113_118dupAGCAGC | p.Gln38_Gln39dup | disruptive_inframe_insertion | 3/13 | ENST00000674280.1 | NP_001364334.1 | |
ATXN7 | NM_001177387.1 | c.113_118dupAGCAGC | p.Gln38_Gln39dup | disruptive_inframe_insertion | 2/13 | NP_001170858.1 | ||
ATXN7 | NM_000333.4 | c.113_118dupAGCAGC | p.Gln38_Gln39dup | disruptive_inframe_insertion | 3/13 | NP_000324.1 | ||
ATXN7 | NM_001377406.1 | c.113_118dupAGCAGC | p.Gln38_Gln39dup | disruptive_inframe_insertion | 2/12 | NP_001364335.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATXN7 | ENST00000674280.1 | c.113_118dupAGCAGC | p.Gln38_Gln39dup | disruptive_inframe_insertion | 3/13 | NM_001377405.1 | ENSP00000501377.1 |
Frequencies
GnomAD3 genomes AF: 0.0975 AC: 14097AN: 144536Hom.: 777 Cov.: 23
GnomAD3 genomes
AF:
AC:
14097
AN:
144536
Hom.:
Cov.:
23
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0492 AC: 510AN: 10356Hom.: 25 AF XY: 0.0484 AC XY: 268AN XY: 5542
GnomAD3 exomes
AF:
AC:
510
AN:
10356
Hom.:
AF XY:
AC XY:
268
AN XY:
5542
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.107 AC: 100873AN: 941440Hom.: 3813 Cov.: 26 AF XY: 0.108 AC XY: 48317AN XY: 446124
GnomAD4 exome
AF:
AC:
100873
AN:
941440
Hom.:
Cov.:
26
AF XY:
AC XY:
48317
AN XY:
446124
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0975 AC: 14106AN: 144638Hom.: 776 Cov.: 23 AF XY: 0.0960 AC XY: 6756AN XY: 70368
GnomAD4 genome
AF:
AC:
14106
AN:
144638
Hom.:
Cov.:
23
AF XY:
AC XY:
6756
AN XY:
70368
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Likely benign
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Retinal dystrophy Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg | Jan 01, 2022 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Poly-Q expansions in this gene associated with spinocerebellar ataxia 7. SCA7 is characterized by progressive cerebellar ataxia, including dysarthria and dysphagia, and cone-rod and retinal dystrophy with progressive central visual loss resulting in blindness in affected adults. Onset in early childhood or infancy has an especially rapid and aggressive course often associated with failure to thrive and regression of motor milestones. Affected individuals usually have greater than 36 CAG repeats, although individuals with fewer repeats may also present with symptoms. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at